Jørn Brynskov Selected Research

Polyps

2/2005

Peroxisome proliferator-activated receptor expression and activation in normal human colonic epithelial cells and tubular adenomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jørn Brynskov Research Topics

Disease

28	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2024 - 01/2009
24	Crohn Disease (Crohn's Disease) 08/2022 - 04/2008
16	Ulcerative Colitis 08/2023 - 02/2006
4	Necrosis 11/2015 - 01/2009
3	Inflammation (Inflammations) 12/2015 - 10/2010
2	Fatigue 04/2023 - 01/2022
2	Adenoma (Adenomas) 12/2015 - 02/2005
1	Herpes Zoster 08/2023
1	Hemorrhage 03/2022
1	Pain (Aches) 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Varicella Zoster Encephalitis (Encephalitis, Varicella) 01/2022
1	Spontaneous Abortion (Miscarriage) 11/2021
1	Infections 11/2021
1	Body Weight (Weight, Body) 01/2021
1	Hypersensitivity (Allergy) 01/2017
1	Pathologic Constriction (Stenosis) 03/2016
1	Communicable Diseases (Infectious Diseases) 11/2015
1	Anaphylaxis (Anaphylactic Shock) 02/2012
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 02/2012
1	Fistula 09/2011
1	Colitis 07/2010
1	Arthritis (Polyarthritis) 02/2006
1	Disease Progression 02/2006
1	Arthralgia (Joint Pain) 02/2006
1	Type 2 Diabetes Mellitus (MODY) 02/2005
1	Polyps 02/2005
1	Carcinogenesis 02/2005
1	Neoplasms (Cancer) 02/2005

Drug/Important Bio-Agent (IBA)

28	Infliximab (Remicade)FDA Link 08/2022 - 04/2008
14	AntibodiesIBA 01/2022 - 04/2008
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2024 - 04/2008
5	Adalimumab (Humira)FDA Link 01/2018 - 02/2012
3	Phenobarbital (Luminal)FDA Link 02/2024 - 02/2012
3	vedolizumabIBA 02/2024 - 11/2021
3	2-mercaptopurineIBA 01/2023 - 01/2018
3	Tumor Necrosis Factor InhibitorsIBA 01/2016 - 10/2010
2	tofacitinibIBA 08/2023 - 01/2022
2	C-Reactive ProteinIBA 01/2022 - 01/2019
2	Fluorescein (Funduscein)FDA LinkGeneric 08/2016 - 04/2016
2	EnzymesIBA 01/2016 - 09/2011
2	Proteins (Proteins, Gene)FDA Link 09/2011 - 01/2009
2	LigandsIBA 07/2010 - 02/2005
2	PPAR gammaIBA 07/2010 - 02/2005
2	Messenger RNA (mRNA)IBA 01/2009 - 02/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2022
1	Azathioprine (Imuran)FDA LinkGeneric 03/2022
1	SteroidsIBA 03/2022
1	Allopurinol (Remid)FDA LinkGeneric 03/2022
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2022
1	Midazolam (Versed)FDA LinkGeneric 01/2022
1	Propofol (Diprivan)FDA LinkGeneric 01/2022
1	AlbuminsIBA 01/2021
1	Thioguanine (Tioguanine)FDA Link 02/2018
1	NucleotidesIBA 02/2018
1	25-hydroxyvitamin DIBA 01/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	Cytokine Receptors (Cytokine Receptor)IBA 04/2016
1	Interleukin-6 (Interleukin 6)IBA 04/2016
1	CytokinesIBA 04/2016
1	17-hydroxyestrane-3-carbonitrile (ECN)IBA 12/2015
1	Biomarkers (Surrogate Marker)IBA 12/2014
1	Peptide Hydrolases (Proteases)FDA Link 09/2011
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2011
1	Matrix Metalloproteinases (MMPs)IBA 09/2011
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 07/2010
1	Rosiglitazone (Avandia)FDA Link 07/2010
1	Mesalamine (Mesalazine)FDA LinkGeneric 07/2010
1	Toll-Like Receptor 8IBA 01/2009
1	Etanercept (Enbrel)FDA Link 01/2009
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2009
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 02/2006
1	Celecoxib (Celebrex)FDA Link 02/2006
1	PPAR alphaIBA 02/2005
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 02/2005

Therapy/Procedure

26	Therapeutics 02/2024 - 02/2006
3	Lasers (Laser) 08/2016 - 12/2015
3	Activities of Daily Living (ADL) 01/2016 - 10/2014
2	Biological Therapy 03/2022 - 01/2022
2	Colectomy 08/2015 - 12/2010
1	Conscious Sedation 01/2022
1	Stents 03/2016
1	Retreatment 05/2012
1	Enema (Enemas) 07/2010
1	Drug Therapy (Chemotherapy) 02/2006